News Hub | News Direct

Unveiling Synoshi Spin Scrubber: Unfiltered Insights and User Experiences

Spark Metro

Synoshi Reviews Scrubbers are essential for the large floors seen in many modern homes, workplaces, and industrial environments. These gadgets, powered by electricity or a rechargeable battery, have brushes or pads that thoroughly clean and scrub various floors, giving them a fresh look. The balancing act between technology and manual operation in the floor scrubber industry guarantees the highest level of efficiency in cleaning. There are many brands of scrubbers as seen in many walk-in stores as well as online stores but not all even delivers a quarter of its promises. The hurt of spending your hard-earned money on a gadget that fails to live up to your expectations can be deep and frustrating. We will analyze the Synonshi power spin scrubber's features, effectiveness, advantages, drawbacks, and overall user experience. This Synoshi Review will help you make an informed decision. Read till the end because we took our time to analyze so many Synoshi Scrubber reviews as well as consumer reports and ratings before putting out this concise piece. Let’s get to it. Overview of the SynoshiPower Spin Scrubber (Synoshi Reviews) The portable, cordless electric Synoshi Power Spin Scrubber is designed to take care of your cleaning. In Japan, almost every home has one of these stylish electric cleaning machines. Being clean is required by Japanese culture and religion, and Synoshi makes this easier to achieve. Cleaning your home just requires a small portion of your time and work. You only need to hold the gadget and move it toward any surface. It's among the most recent and potent cleaning technologies available. The gadget was designed to combine current technology with the passion for cleanliness found in Japan to create something anyone could use. The gadget features a creative L-shaped design. The sharp edge is where the brush head is fastened. The three brush heads—two of which are sold separately—can be used to clean various surfaces. Synoshi can reach dirt anywhere, whether on smooth surfaces, in small places, or corners. You don't have to spend hours scrubbing, mopping, and wiping when you use Synoshi for cleaning. It eliminates most of the tension associated with cleaning and reduces cleaning time by more than half. Many Synoshi Reviews in the United States, Canada and Australia claim the Synoshi Scrubber's better comfort, multifunctional design, robust features, and elegant, sleek design outperform many power scrubbers. There aren't many Synoshi left in stock, so you'll need to act quickly and order from the product's official website before it disappears from the market. Does the Synoshi Scrubber Really Work? Synoshi is just as effective as any brush, scrubber, or sponge that money can purchase. The main distinction is that Synoshi completes the task faster. Numerous Synoshi Reviews confirm that it's a fantastic approach to boost hygiene and cleaning effectiveness around your house. Because the Synoshi Power Scrubber is a third-generation cleaning instrument, customers and consumers are quite delighted with its technology. The Synoshi is easy to use and has several cutting-edge qualities, such as being cordless, rechargeable, lightweight, chemical-free, reasonably priced, eco-friendly, effective, and so on. Why Does the Synoshi Power Spin Scrubber Work So Well ToStop Harmful Germs and Mold? The Synoshi is made to reach even the hardest-to-reach places where harmful mold and bacteria tend to grow, which is one of the key reasons why Synoshi is so good at preventing them. Using a bleach solution or a specialized anti-fungal, anti-microbial, anti-bacterial cleaner made especially for eliminating mold and bacteria is the best approach to eradicate hazardous mold and bacteria from the hard-to-reach corners, cracks, and crevices in your home. That's okay also if you'd rather use a more natural cleaning solution, like hydrogen peroxide or white vinegar; just make sure to give it extra time to soak in order to destroy the bacteria and mold. When using hydrogen peroxide, you should usually wait at least 10 to 15 minutes for the solution to settle before using the Synoshi Power Spin Scrubber to scrub the area. Let the vinegar soak for at least sixty minutes if you're using white vinegar. The next step is to let the scrubber do its magic once you've given the cleaning solution enough time to penetrate into the confined spaces where harmful mold and germs can hide. Mold and bacteria are no match for the strong spinning action and the hard-bristle brush choice. The scrubber's design also makes it easy for it to reach nooks and crevices that other cleaning instruments might not be able to. MUST SEE: Click Here To Get The Synoshi Directly From The Official Website At A Massive Discount Standout Features (Synoshi Scrubber Reviews) Multipurpose: This instrument has numerous uses, including cleaning a wide range of objects and surfaces. Many users use it in cramped areas and on smooth surfaces. Several cleaning heads: The Synoshi Power Spin Scrubber can clean stoves, glass, kitchen counters, doors, windows, tires, and even pots and pans. Cordless: You can place an electric outlet in your bathroom without worrying about getting caught in wires. Focus only on tidying the area in front of you. Strong battery life + Rechargeable: Synoshi can operate at maximum efficiency for up to 45 minutes after a full charge. If your apartment is the average size, you will have more than enough time to complete most of your cleaning. Effortless cleaning: It can be very taxing to manually remove all of the filth, soap scum, grime, and tile grout. Most of the cleaning, brushing, and wiping is done by The Synoshi Power Spin Scrubber while it rotates, saving you the trouble. You save more effort and energy in this way. It's the epitome of semi-automation. Waterproof: In damp environments, the Synoshi Power Spin Scrubber performs admirably. You can safely clean your sinks, showers, and even pools! To keep your scrubber clean, just wash it under running water if it gets dirty. Is The Synoshi A Scam? As customers look for cutting-edge solutions to make domestic chores easier, concerns over the reliability of these goods is a factor. Does the Synoshi Scrubber belong in the category of questionable devices, or is it a dependable addition to your cleaning supplies? Now, let's explore the features that support the validity of the Synoshi Spin Power Scrubber. The official website is one of the main markers of a product's validity. The Synoshi website is unique in its polished appearance and provides thorough and understandable product details. The official website is a trustworthy resource for prospective customers, offering comprehensive information on everything from features to technological details. Having safe payment choices ensures that users may confidently complete transactions. An important factor in assessing a product's genuineness is its customer reviews. Prospective purchasers searching the internet for reviews have found that the Synoshi Spin Power Scrubber has received favorable comments on several sites. Customers vouch for the product's efficacy by praising its ability to remove stubborn stains and dirt from various surfaces. Sincere endorsements from contented clients help to strengthen confidence in the Synoshi Scrubber's validity. Real companies always have a safe and trustworthy return policy in place. This is one area where the Synoshi Scrubber excels, providing a clear return policy outlining the criteria and circumstances for product returns. This dedication to client pleasure shows a sincere desire to offer a trustworthy and efficient cleaning solution. While it's important for buyers to do their research before making any purchases, the Synoshi Scrubber appears to be a reliable and practical tool for streamlining domestic cleaning duties. What Sets TheSynoshi Apart? Saves you money and time: Synoshi is also an excellent option if you detest cleaning so much that you must pay someone. Most of the scrubbing and rinsing is done by the reasonably priced gadget. Of course, you have to put in a little work, but when you think about the savings, it is well worth it. Synoshi Makes Life Much Easier: Synoshi is used by several families around Japan. Both sexes use them to increase cleaning productivity. The main trick to Japan's clean surroundings is using cleaning supplies like Synoshi. When people use them, their cleaning tasks are completed quickly, giving them more time for leisure and relaxation. Older people love Synoshi more than anyone else. It is ideal for them because it requires little energy and does not put undue strain on their delicate joints and muscles. Fast cleaning: Synoshi cordless portable electric scrubber is a handheld cleaning tool that helps clean your home quicker and simpler. No need for additional purchases: The only cleaning tool you'll require! Discard all of your additional cleaning supplies. The only tool you'll need to clean every surface in your house is Synoshi. Clear the dirt from the corners of your house: Your home's corners can accumulate dirt and grime. The locations will become clean once more because Synoshi was made to fit through these gaps. Use it anywhere you go: Synoshi is a one-stop shop for anything from pans and pots to shoes, your car, bike, and home! Affordable: Save your money where it belongs—in the bank. Having your house cleaned shouldn't be costly. You can save a ton of money on cleaning materials by using Synoshi. Who Needs The Synoshi? The Synoshi Spin Power Scrubber is a ground-breaking cleaning product that completely changes how people clean their homes. This portable gadget, made for a wide variety of users, is intended to simplify and increase cleaning effectiveness. The Synoshi Scrubber is a time-saving lifesaver for people who lead busy lives. Its strong rotating brush head removes stubborn dirt and stains from various surfaces while requiring less time and effort to scrub. Because of its versatility in cleaning various surfaces, the Synoshi Scrubber is a valuable tool for anyone renting or owning a property. The Synoshi Scrubber is an invaluable ally for families with little children. Its chemical-free cleaning method removes the need for harsh cleaning agents, ensuring a child-safe environment. For families with young children, the device's effectiveness in eliminating pollutants, hard water stains, and soap scum helps to create a healthy home environment. The Synoshi Scrubber is an environmentally friendly cleaning solution. Because of its long-lasting design and rechargeable battery, it eliminates the need for single-use batteries, which aligns with the desires of environmentally aware people looking for efficient and sustainable cleaning solutions. The Synoshi Scrubber is handy for elderly people who might find traditional scrubbing physically taxing. With its strong motor and portable design, it can clean effectively without requiring much work, so elders can enjoy a clean home without the physical strain of hand scrubbing. The Synoshi can benefit individuals from all walks of life! Synoshi Reviews: Pros Fast cleaning Multipurpose tool Handheld and cordless It is incredibly sturdy and resistant to water. Synoshi is offered for a fair price. flawless outcomes easily cleans corners special offer of 50% off 100% money-back return guarantee Synoshi Reviews: Cons You cannot buy Synoshi in local retail establishments. Synoshi is exclusively available for purchase online via the product's official website. Limited in stock Price Of Synoshi Power Spin Scrubber We have included the available packages and associated costs to help you choose the plan that best suits your needs. Purchase 1X Synoshi Spin Power Scrubber for $35.96 Purchase 2X Synoshi Spin Power Scrubbers for $49.96 Purchase 3X Synoshi Spin Power Scrubbers for $69.96 Purchase 4X Synoshi Spin Power Scrubbers for $85.56 Where Can I Buy TheSynoshi In The United States, Canada, And Australia? Ordering a Synoshi online is possible through the official Synoshi scrubber website. This is the only approved place to buy this smart cleaning device. The consumer is also offering a 50% reduction on the list price. Therefore, if you act quickly and place your order, you might be one of the fortunate ones. This promotional discount offer is only available while supplies last and may be removed anytime. CLICK HERE NOW TO GET THE SYNOSHI SPIN SCRUBBER FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Synoshi Reviews Consumer Reports Below are some of the most recent user reviews of Synoshi: Kennedy M - I hate germs and bacteria, and that's why I do a pretty decent job of cleaning my home. Unfortunately, I always use solutions that contain ammonia or chlorine, which can be pretty dangerous. Glad I don't have to use them anymore because this Power Spin Scrubber takes care of all the dirt without compromising my health. Olivia W - Synoshi really stepped it up with this Power Spin Scrubber. It's not easy to get down on my knees to scrub tiles at 55 years old. I needed a solution that would help me clean with minimal effort and less strain on my joints and muscles. I found Synoshi, and that's a problem solved for me. Synoshi Reviews: FAQs What are the parameters of Synoshi? The Synoshi measures 11.5 by 18 centimeters and features a 10W power source. At just 300g, it is incredibly light. Is Synoshi water resistant? Synoshi is waterproof in a running sink or shower. But you shouldn't immerse the gadget entirely in water. How do I charge it? A USB Type C charger is used to charge Synoshi. How much time can Synoshi run on a single charge? A single charge can cover your entire home cleaning with Synoshi's 45-minute running time! What comes with my Synoshi package? The Scrubber itself, one circular gray brush, one charging wire, and the handbook. Is Synoshi’s operation noiseless? A: Certainly! Synoshi scrubs quite quickly, but it is incredibly silent and rarely vibrates. Conclusion on Synoshi Spin Power Scrubber Reviews In summary, the Synoshi Spin Power Scrubber is a home and individual game-changer that is more than just a cleaning tool. The Synoshi Scrubber is a practical, effective, and eco-friendly answer to your cleaning needs, whether you are a busy professional, a family with young children, an eco-aware person, or a small cleaning company owner. The Synoshi Scrubber is positioned to completely change how we clean our homes because of its cutting-edge features and favorable evaluations. Furthermore, many online Synoshi Reviews have hailed the cleaning gadget as one that is presently changing how people clean their houses. It has many incredible features, many of which are characteristic of third-generation cutting-edge technology. Performance is enhanced by the strong two-gear motor it possesses and it is cordless with several brush heads. Cleaning becomes much quicker, simpler, and more effective using Synoshi. Therefore, this is a must-have for you if you want to accomplish cleaning jobs faster and with deeper cleaning. Right now, many people who value cleanliness are placing Synoshi orders. Inspired by Japanese hygiene culture, this wonder item has everyone vying for a piece. CLICK HERE NOW TO GET THE SYNOSHI DIRECTLY FROM THE OFFICIAL WEBSITE AT A MASSIVE DISCOUNT Contact Details Reviewzenith Alex +1 302-597-6768 Apexreviews154@gmail.com

December 28, 2023 01:27 AM Eastern Standard Time

Image

Antibiotics - They’re amazing, but they don’t work on viral infections like the cold and flu

YourUpdateTV

As consumers struggle to navigate yet another heavy-hitting cold and flu season, it is important to uncover the misconceptions surrounding the alarming overuse of antibiotics, especially the misuse in treating viral infections like the common cold and flu. Recently, Dr. Ken Redcross, conducted a satellite media tour to share tips and advice on how to safely and effectively manage cold or flu symptoms. A video accompanying this announcement is available at: https://youtu.be/0aIOL11vnss Every year, approximately 2.8 million antibiotic-resistant infections occur and 35,000 people in the US die from Antimicrobial Resistance (AMR), a global health emergency caused by common misconceptions about the effectiveness of antibiotics in treating cold and flu symptoms, which over time can lead to rampant antibiotic overuse and antibiotic resistance. To raise awareness of this global health crisis and help fight these misconceptions, Mucinex – a brand made by Reckitt which clears the way for people to make powerful comebacks from sickness with its line of over-the-counter cold and flu medications – is launching its new “Flip the Script” campaign. This multi-pronged initiative aims to educate consumers about the widespread inappropriate use of antibiotics currently plaguing the U.S. and the world at large. The brand will partner with Urgent and Primary Care Centers to help address this issue. There’s a reason for that: 7 in 10 Urgent Care Center patients ask their doctor for an antibiotic and 45.7% of inappropriate antibiotic prescriptions for Respiratory diagnoses were from Urgent Care centers. That’s why Mucinex plans to roll out signage and educational materials at Urgent and Primary Care Centers, as well as a series of educational videos and audio PSAs online, which clearly explain why OTC products like Mucinex – not antibiotics – are still the best option for treating cold and flu symptoms. Antibiotic Resistance caused partly by this misuse of antibiotics is a leading cause of death worldwide. This misuse stems largely from two common and incorrect misconceptions: that antibiotics are the best line of defense against cold and flu symptoms and that antibiotics are essential when cold and flu symptoms last longer than two or three days. Mucinex’s partnership with Urgent and Primary Care Centers throughout the nation will focus on states that have a high index of certain AMR strains and antibiotic prescriptions per population. How can consumers Flip the Script? Those who visit participating urgent care centers will find educational materials about antibiotic resistance, urging them to reach out to their physician when feeling unwell so that the proper treatment can be prescribed. Should the physician recommend an over-the-counter medication, they can share a “prescription” with the patient—an informative flipped brochure about antibiotics vs. OTC medication — that includes a Mucinex coupon, making it simpler to relieve your worst cold and flu symptoms at any time, day or night. For more information on the campaign and real-life examples of people struggling with the effects of AMR, visit the “Flip the Script” landing page on the Mucinex website at Mucinexfight.com. For more information on Mucinex, visit www.Mucinex.com. ABOUT: Dr. Ken Redcross, M.D. Dr. Redcross is a board-certified Internal Medicine physician. His expertise is capturing how to best provide the ultimate patient experience for those frustrated with the deterioration of the patient-doctor relationship. His concierge approach has led to the development of an impressive following of patients from the entertainment industry, sports world and business leaders spanning from Los Angeles to New York City. Dr. Redcross has reached tens of millions of people through media appearances including The Doctors, Entertainment Tonight and the Nancy Grace Show. He has been a medical expert for CNN Travel appeared regularly on HLN Weekend Express and has contributed articles for and digital health and wellness companies, including Everyday Health. Dr. Redcross has worked with a diverse group of patients, spanning from the elderly to migrant farm workers, to patients battling heroin addiction. He participated in fellowships in Puerto Rico and the Dominican Republic, contributing to his proficiency in Spanish. In 2001, Dr. Redcross completed his medical training at the prestigious Columbia-Presbyterian Medical Center, followed by providing care in rural Oxnard, CA and finally transitioning to the renowned Cedars-Sinai Medical Center in Beverly Hills. Following his year of accumulated training and experience, he created his Concierge practice in 2007, and established his wellness company, Ken Redcross Communications, Inc. As an author, Dr. Redcross shares his nearly 20 years of experience in his book, Bond: The 4 Cornerstones of a Lasting and Caring Relationship with Your Doctor, where he highlights the four cornerstone qualities essential to creating a life-long patient-doctor bond. Bond was the Amazon Number One New Release in Medicine & Psychology. Among his many honors, Dr. Redcross received the Man of Valor Award from NAACP Youth Council for excellence in medicine and most recently, was named a Top 25 Concierge Physician in the U.S. Embracing both natural and alternative methods of healing in his practice, Dr. Redcross received the honor of being selected Educator of the Year by the Nutrition Business Journal (NBJ). He firmly believes that proactive treatment is the goal, and if medical challenges arise, they should be met with support through the creation of a health strategy. With the correct balance of nutrition, movement, and spirituality we can live our best life experience. Currently, Dr. Redcross focuses on utilizing the BOND program to consult for health networks and companies to provide their customers with better outcomes while serving as an advocate, educating, empowering, and offering peace of mind to patients and their families. About Reckitt Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege. Reckitt is the company behind some of the world's most recognizable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more. Every day, more than 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always. We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com/us. * Reckitt is the trading name of the Reckitt Benckiser group of companies [1] The Lancet Journal – Global Burden of Bacterial Antibiotic Resistance in 2019 [2] CDC 2019 Antibiotic Resistance Threats Report [3] 2022 Mucinex Urgent Care Patient Study [4] 2018 JAMA report - Overprescription in Urgent Care Clinics Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

December 26, 2023 10:39 AM Eastern Standard Time

Video

Neural Therapeutics CEO defines success and senses "a lot of momentum" behind psychedelics

Neural Therapeutics Inc.

Neural Therapeutics Inc CEO Ian Campbell speaks to Thomas Warner from Proactive about his vision for revolutionising mental health treatment. The company is working to develop medicines from from the San Pedro plant, in a challenge to traditional pharmaceutical methods that typically isolate single compounds. Campbell, with a diverse background in physical sciences, biology, toxicology, and engineering, explains that he transitioned to this field driven by a desire to contribute positively to humanity. His journey reflects a commitment to lifelong education and a passion for impactful scientific innovation. The CEO's personal connection to mental health issues within his family further motivates his mission, receiving supportive feedback from his family on this career shift. Currently, the company is focused on advancing their treatment into human clinical trials, navigating regulatory challenges and exploring the potential of botanicals in pharmaceuticals. Campbell's goal is to fast-track the drug's development, backed by evidence of mescaline's efficacy in treating various mental ailments. He says success for him would be "our product being delivered to humans." Contact Details Proactive United States Proactive United States +1 347-449-0879 action@proactiveinvestors.com

December 21, 2023 08:20 AM Eastern Standard Time

Video

News Release

ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex

ReShape Lifesciences Inc

ReShape Lifesciences CEO Paul Hickey joined Steve Darling from Proactive to share significant news regarding the approval of the company's next-generation Lap-Band® 2.0 FLEX by the U.S. Food and Drug Administration. Hickey told Proactive this FDA approval represents a historic event for ReShape Lifesciences and is expected to serve as a pivotal driver of growth for the company's Lap-Band franchise. The development of the enhanced Lap-Band 2.0 FLEX was led by physicians with a primary focus on improving the overall patient experience. This FDA approval marks a significant milestone for ReShape Lifesciences, highlighting the company's commitment to advancing patient-centered innovations in the field of medical devices. Contact Details Proactive USA +1 347-449-0879 na-editorial@proactiveinvestors.com

December 21, 2023 07:00 AM Eastern Standard Time

Video

Polarean Imaging "very excited" to announce brand new customer for XENOVIEW polariser

Polarean Imaging PLC

Polarean Imaging PLC (AIM:POLX, OTC:PLLWF) CEO Christopher von Jako speaks to Thomas Warner from Proactive after the medical imaging technology company announced its first de novo order for its XENOVIEW polariser. Von Jako explains that the latest order, from a renowned medical institution in the Northeast, represents a significant step as it is from a brand new customer. Von Jako, who took the helm in July, also highlights the company's work with Dutch multinational Philips, emphasising the seamless integration of their products, including FDA-approved MRI coils. This collaboration extends to training Philips' commercial staff in the U.S., promising further growth in 2024. Additionally, Polarean is pursuing strategic growth initiatives, including increasing utilisation of their technology at sites like Cincinnati Children's Hospital and the University of Missouri. The company is also focusing on expanding its footprint and establishing Medicare reimbursement, thus enhancing its financial viability. Another key initiative involves conducting a clinical trial for FDA approval to explore new lung functions, potentially revolutionising lung imaging technology. In terms of financials, von Jako expressed confidence in closing the funding gap by the third quarter of the next year, supported by strategic investors. Contact Details Proactive UK Ltd Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

December 21, 2023 06:55 AM Eastern Standard Time

Video

The 2023 VinFuture Prize honored four scientific works under the theme of "Boundless Unity"

Vingroup

HANOI, VIETNAM - Media OutReach Newswire - 21 December 2023 - The VinFuture Foundation has honored four scientific breakthroughs in 2023. The US$3 million Grand Prize was awarded to the "Invention in creating a sustainable platform for green energy through production with solar cells and storage with Lithium-ion batteries." Three VinFuture Special Prizes were awarded to "Invention and advancement of disease-resistant rice varieties", "The discovery of the ozone depletion mechanism in Antarctica", and "The discovery of the role of glucagon-like peptides-1 (GLP-1), paving the way for widely used treatments for diabetes and obesity." The 2023 VinFuture Prize Award Ceremony was broadcast live nationally on Vietnam National Television VTV1. The ceremony was graced with the presence of His Excellency Vo Van Thuong - the President of the Socialist Republic of Viet Nam, and leaders of domestic ministries and departments, international ambassadors, and eminent scientists from around the world. The four winning works surpassed nearly 1,400 impressive nominations originating from 90 countries and territories. These breakthroughs have a profound impact on the present and future of humanity in crucial fields such as green and sustainable energy, climate change response, sustainable agriculture, food security, and healthcare, impacting the lives of billions of people worldwide. Remarkably, all the projects share a common thread of collaboration between developed and developing countries, leveraging the diversity of different groundbreaking inventions. Through this, the awarded breakthroughs have created comprehensive technologies of global significance, contributing to the construction of a sustainable future for humanity. Speaking at the Award Ceremony, President Vo Van Thuong said: "With a global vision and a "Boundless Unity" approach, the VinFuture Prize recognizes and honors scientists who have outstanding research works. Innovative and groundbreaking technologies with high practical applications are crucial for enhancing people's lives and fostering connections within the worldwide scientific community. Since the first series of the award until now, the VinFuture Prize has consistently pursued its mission of "science for humanity" with a focus on the four core values: Equality, Global Reach, Sustainability, and Pioneering. It has achieved steady growth in quality, quantity, and diversity, as well as gained increasing international attention, influence, and reputation. The President also affirmed that: "The success of the VinFuture Prize as a well-deserved outcome of the founder's diligent and committed efforts. I express my appreciation and congratulations to the founders who established this Award." The 2023 VinFuture Grand Prize was awarded to four scientists: Prof. Martin Andrew Green (Australia), Prof. Stanley Whittingham (United States), Prof. Rachid Yazami (Morocco), and Prof. Akira Yoshino (Japan) for their breakthrough inventions in creating a sustainable platform for green energy through production with solar cells and storage with Lithium-ion batteries. The combination of these transformative projects spearheaded a revolution in sustainable green energy solutions for the modern world. Prof. Martin Green and his research team pioneered the Passive Emitter and Rear Contact (PERC) technology, elevating energy conversion efficiency from 15% to an impressive 25%. These advancements deliver exceptional utilities, even in regions with limited sunlight conditions. Since its mass production in 2012, PERC solar cells have commanded a significant 60% share of the global solar cell market. Meanwhile, the advent of Lithium-ion battery storage has extended the reach of energy consumption across all geographical regions and socioeconomic classes, providing widespread access to green and sustainable energy solutions. Lithium-ion batteries power 15 billion mobile devices and 26 million electric vehicles globally, thanks to the work of outstanding scientists: Prof. Stanley Whittingham, Prof. Rachid Yazami, Prof. Akira Yoshino, and the late Prof. John Goodenough. The award ceremony also paid tribute to and honored the late Prof. John Goodenough – a pioneering scientist whose invention enabled Lithium-ion batteries to be safely rechargeable for the first time, improving the efficiency and saving resources. The synergy of these two groundbreaking technological revolutions has promoted the widespread adoption and accessibility of clean energy in our everyday lives through the conversion of solar energy into electricity by PERC solar cells and storage by Lithium-ion battery. In addition to the Grand Prize, three Special Prizes, each valued at US$500,000, have been awarded to innovators with outstanding achievements in emerging fields, female innovators, and innovators from developing countries. The 2023 VinFuture Special Prize for Innovators with Outstanding Achievements in Emerging Fields is awarded to Prof. Daniel Joshua Drucker (Canada), Prof. Joel Francis Habener (United States), Prof. Jens Juul Holst (Denmark), and Assoc. Prof. Svetlana Mojsov (United States) for the "discovery of the role of glucagon-like peptide-1 (GLP-1), paving the way for widely used treatments for diabetes and obesity and stimulating emerging applications for neurodegenerative diseases". The 2023 VinFuture Special Prize for Innovators with Outstanding Achievements in Emerging Fields is awarded to Prof. Daniel Joshua Drucker (Canada), Prof. Joel Francis Habener (United States), Prof. Jens Juul Holst (Denmark), and Assoc. Prof. Svetlana Mojsov (United States) Their work lays the foundation for the treatment of many diseases, including type-2 diabetes, obesity, and short bowel syndrome, positively impacting more than 400 million people with type-2 diabetes, more than 1 billion people with obesity, and more than 3 million people with short bowel syndrome. In 2023, more than 20 million doses of GLP-1 drugs have been used in the world, with an impressive 6.7% increase in adoption. In addition, the discovery of the peptide's acting mechanism has promoted research and development of novel treatments for cardiovascular diseases and neurodegenerative diseases, such as Alzheimer's and Parkinson's, which are among the leading causes of death globally. The 2023 VinFuture Special Prize for Innovators from Developing Countries has honored Indian American Prof. Gurdev Singh Khush and Vietnamese Prof. Vo Tong Xuan for their significant contributions to the invention and advancement of disease-resistant rice varieties, ensuring global food security. Professor Khush pioneered the development of rice cultivars with pest resistance, short growth periods, and high yields, such as IR36 and IR64. Among them, IR64 and its descendants have been widely grown in many countries, including the Philippines, Indonesia, Bangladesh, and India, while IR36 is popular in the Mekong Delta of Vietnam, which is regularly plagued by pests. Thanks to the significant efforts of Prof. Vo Tong Xuan, IR36 and IR64 rice varieties are currently the most common in tropical Asia, helping to cut production costs, enhance yield, restrict pesticide use, and promote global agricultural sustainability. The 2023 VinFuture Special Prize for Female Innovators has honored Prof. Susan Solomon (United States) for the discovery of the ozone depletion mechanism in Antarctica, contributing to the establishment of the Montreal Protocol. Prof. Solomon gathered credible information about the unusually large hole in the ozone layer caused by chlorofluorocarbons (CFC) in Antarctica, laying the groundwork for proposing and bringing the Montreal Protocol to fruition. This is one of the most successful international accords in tackling global environmental concerns, contributing to a global agreement to phase out ozone-depleting compounds like CFCs. According to released data from 2016, the ozone hole has been reduced by more than 4 million square kilometers since its peak in 2000 and will entirely regenerate in the coming decades. The Montreal Protocol has made a substantial contribution to the protection of the global climate system and is expected to prevent an additional 100-200 billion tons of CO2 emissions by 2050, potentially reducing the global temperature increase from 2-5°C to 0.5°C by 2100. Commenting on the results of the 2023 VinFuture Prize, Professor Sir Richard Friend, VinFuture Prize Council Chair, stated, "We are very excited to have announced our new VinFuture Prize winners. They have all made huge advances in science and innovation, and these have had real global impact. The Grand Prize recognizes the pioneers in two of the critical technologies we need to achieve zero-carbon energy that are critical if we are to control global warming. The breadth of scope to bring science and innovation to benefit society is huge, as reflected by this year's three Special Prizes. The vision that the Founders set – to celebrate the potential for discovery and innovation to bring real benefits to societies across the whole globe – is very clearly delivered in the set of this year's prize winners." The spirit of "Boundless Unity" for the benefit of humanity unites the four award-winning projects in a meaningful way. When individual scientific accomplishments synergize, they help to establish a sustainable foundation for humanity. The VinFuture Prize differs from other prestigious international awards in that it recognizes the cross-border collaboration of global scientists. With the success of the third award season, the VinFuture Prize upholds its reputation among the international scientific community owing to the comprehensiveness, diversity, and fairness of the judging process. The VinFuture Foundation is proud to continue its mission of "Science for Humanity" and inspiring innovation in Vietnamese science and technology, contributing to a prosperous, equitable, and sustainable future for all people worldwide. About the VinFuture Prize The VinFuture Prize is the core activity of the VinFuture Foundation, a non-profit organization established on International Human Solidarity Day on December 20th, 2020, co-founded by billionaire Mr. Pham Nhat Vuong and his wife, Mrs. Pham Thu Huong. The VinFuture Prize aims to recognize transformative scientific and technological innovations capable of making significant positive changes in the lives of millions of people worldwide. 2024 VinFuture Prize Official Call for Nominations The fourth award season of the VinFuture Prize has now begun, following the 2023 VinFuture Prize's conclusion. An official call for nominations will be launched from 2:00 p.m. on January 9, 2024 to 2:00 p.m. on April 17, 2023, Hanoi time (GMT+7).The award honors advances in science and technology that are aligned with the United Nations' 17 Sustainable Development Goals (SDGs), such as eradicating poverty, ending hunger, improving health and quality of life, creating opportunities for progressive education, clean water, renewable energy, reducing inequality, and responding to climate change. Nominators can submit their nominations by logging into this portal: https://online.vinfutureprize.org/nomination. Contact Details Media Contact v.chidqd1@vingroup.net

December 21, 2023 04:02 AM Eastern Standard Time

Image

New Study From San Antonio Breast Cancer Symposium Proves Innovative Marker Makes It Easier for Physicians to Detect and Remove Cancer Than Ever Before

Endomag

Research presented at the San Antonio Breast Cancer Symposium (SABCS) has found that surgeons and radiologists are moving away from one of the oldest traditional methods for locating and removing breast cancer, in favour of newer and more innovative technologies. The seminal study found that since 2020, usage rates of the guidewire – the standard in breast cancer surgery for over 60 years - has fallen from 83% of physicians using the device, to just 18%. In comparison, the rise of a unique metallic seed called the Magseed® marker has seen its adoption levels soar to 49%, meaning it has replaced the guidewire as the most used method for cancer localization. Having gained FDA approval in 2015, the Magseed has helped over 250,000 patients worldwide to access minimally-invasive, wire-free breast cancer care. Gone are the days of a patient attending an early appointment to have a guidewire placed on the day of their surgery, and having to wait around the hospital until the time of operation. Now, patients have the option of the Magseed being placed into the cancerous tissue any time ahead of surgery, at a time that suits them, safe in the knowledge it won’t move and can be easily found when the surgery takes place at a later date. “This study demonstrates that the modern solutions to localization are providing such a vast improvement for patients and the physicians using them, that they have been able to be rapidly adopted across the hospital setting.” said Mr. James Harvey, Oncoplastic Breast Surgeon and author of the study presented at SABCS 2023. The study from SABCS also surveyed each of the participating surgeons and radiologists, to understand the quality of user experience for each of their chosen devices for localizing tumors. Participants were asked about a range of topics including the reliability of locating the device, accuracy of cancer removal and the logistical benefits that the technology provides to the hospital. Once again, the results showed a significant benefit in favour of the wire-free Magseed device. On average, radiologists gave the device 9/10 for overall satisfaction, while surgeons scored it 8/10. In comparison, the guidewire received 7/10 scores from both audiences. “This is the first study to demonstrate that radiologists and surgeons now find Magseed to be more effective in patient care and a significant improvement on prior technologies.” continued Mr. Harvey. It is also the first study to ascertain the advantages and disadvantages of each localization device against one another. The findings here could now have far-reaching implications for breast cancer treatment across the world. The shift towards Magseed as the preferred localization device indicates there is growing interest in new technologies that improve patient outcomes. The landscape is changing for breast surgery, and it’s helping to drive ongoing research and innovation in cancer care. -ENDS- Notes to Editors: In the study, participants were asked to rate a range of features on a scale from 1-10 (10 being the highest level of satisfaction). Please find poster attached alongside this press release. This iBRA-NET satisfaction study includes findings from 84 breast units (65% of all UK sites), and was published at the San Antonio Breast Cancer Symposium on 7th December 2023. The Sentimag platform, along with Magseed marker and Magtrace lymphatic tracer, was developed by Endomag and is distributed by Mammotome in North America. More than 450,000 women have now received a better standard of breast cancer surgery with Endomag’s technologies. The Sentimag® is in use at over 1,000 hospitals in more than 45 countries across the world. About Us At Endomag, we believe everyone deserves a better standard of cancer care. That’s why we design our magnetic technologies with both the clinician and patient in mind. Many leading hospitals across the world use our unique solutions to help breast cancer patients avoid surgery when it isn’t needed, and experience better outcomes when it is. At the heart of the company’s technologies is the Sentimag® localization system. The Sentimag® system features a probe which works like a metal detector. When it is placed near the skin’s surface, it can detect Endomag’s magnetic seed marker (Magseed®) and liquid tracer (Magtrace®), for accurate lesion localization and sentinel lymph node biopsy procedures. Endomag’s technologies have already helped 450,000+ women worldwide to access more precise, and minimally invasive breast cancer treatment. Contact Details Endomag Mary Nicholls +44 1223 652540 mnicholls@endomag.com

December 20, 2023 10:50 AM Eastern Standard Time

Image

Protecting Yourself from Respiratory Illnesses this Holiday Season

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/ZW6KvqOsf9M The holiday season is in full swing, and it's crucial to safeguard ourselves, our children, and our communities against respiratory illnesses like the outbreak we are seeing in China. Just when we thought it was safe to travel and gather for the holidays, pneumonia and RSV outbreaks here in the US and around the Globe are rising. With all the shopping, planning, cooking, and traveling, nobody wants to spend the holidays in bed sick or maybe even in the hospital fighting nasty viruses that continue to circle the globe. A nationwide media tour was conducted featuring President of the College of American Pathologists, Dr. Donald Karcher, sharing some tips on keeping you and your family safe when celebrating the holidays. Topics during the media tour that President of the College of American Pathologists, Dr. Donald Karcher, discussed included: · An understanding of exactly what is happening and how concerned we should be. · What can parents look for and do to mitigate the illness and the effect on the rest of the family, including elderly friends and relatives? · Why testing is still so important in corralling these illnesses. For more information, visit Newsroom.CAP.ORG Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

December 19, 2023 02:22 PM Eastern Standard Time

Video

Cardio Diagnostics’ Breakthrough Coronary Heart Disease Detection Test Published In The Journal Of The American Heart Association

Cardio Diagnostics Holdings, Inc

By Jeremy Golden, Benzinga Cardio Diagnostics (NASDAQ: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine, has published a potentially revolutionary study in the Journal of the American Heart Association (JAHA). Conducted in collaboration with Intermountain Healthcare and University of Iowa Hospitals and Clinics, the publication details the development and validation of PrecisionCHD, a pioneering artificial intelligence-guided integrated genetic-epigenetic test for detecting coronary heart disease (CHD). Titled "The Validation of an Integrated Genetic-Epigenetic Test for the Assessment of Coronary Heart Disease," the article sheds light on Cardio Diagnostics’ progress in the field of cardiovascular medicine while showcasing PrecisionCHD’s ability to detect CHD with high sensitivity with a blood test and provide better testing access to underserved communities. Democratizing Access Traditional diagnostic methods for CHD, often inaccessible due to the need for specialized infrastructure, can be invasive and sometimes require exposure to ionizing radiation. Additionally, some of the tests are not sensitive to all forms of CHD and can be very costly, leaving millions of Americans without adequate and potentially lifesaving cardiac care. PrecisionCHD is the first integrated genetic-epigenetic test for the detection of CHD. With the introduction of PrecisionCHD, clinicians are armed with a powerful, scalable and non-invasive alternative that comes in the form of a blood-based test that uses artificial intelligence (AI), along with personalized genetic and epigenetic information, to detect the presence of CHD. Those who read the JAHA publication will learn about the development and validation of the PrecisionCHD test in three independent cohorts totaling 2,516 individuals. The study was collaboratively conducted by researchers from Cardio Diagnostics, Intermountain Healthcare and the University of Iowa Hospitals and Clinics. PrecisionCHD uses the input from six methylation sensitive digital PCR (MSdPCR) assessments to determine the presence or absence of CHD. The article details the mapping of each of these MSdPCR assays to distinct modifiable drivers of CHD, through which clinicians are able to gain personalized insights into each patient’s CHD presentation. It also notes that because methylation is dynamic, clinicians can consider focused re-testing to determine the effectiveness of CHD therapy. “What's truly revolutionary about this approach is its ability to provide a more comprehensive, personalized snapshot of a patient's CHD drivers, allowing for early intervention and tailored treatment plans,” said Robert Philibert MD Ph.D., lead author and Chief Medical Officer of Cardio Diagnostics. “This is personal for me; seeing patients who previously had limited options for early diagnosis now have access to this state-of-the-art technology is a milestone in cardiac care.” For rural communities where access to specialized medical facilities is limited, the implications of this research are particularly relevant. With only a simple blood draw needed to complete a test, PrecisionCHD offers patients in underserved areas access to state-of-the-art cardiac assessments. PrecisionCHD can be administered in primary care or telemedicine settings, significantly reducing the need for patients to travel to distant specialized clinics. This level of availability marks a step forward toward mitigating healthcare disparities, especially in rural areas with limited resources and infrastructure. “Our commitment is to democratize access to essential cardiac care, particularly in rural areas where advanced diagnostic tools are scarce and cardiovascular specialists are even more rare,” said Meesha Dogan, Ph.D., CEO and Co-Founder of Cardio Diagnostics. “PrecisionCHD's remote accessibility and deployment capability in non-specialized settings are pivotal in achieving this goal.” After recently finalizing an Innovation Technology contract with Vizient, Inc. – the nation’s largest provider-driven healthcare performance improvement company – Cardio Diagnostics will have access to a customer base that encompasses 60% of hospitals and 97% of academic medical centers in the United States. Member institutions have the ability to purchase the PrecisionCHD test through Vizient’s Innovative Technology Program. Cardio Diagnostics is an artificial intelligence-powered precision cardiovascular medicine company that makes cardiovascular disease prevention, detection, and management more accessible, personalized, and precise. The Company was formed to further develop and commercialize clinical tests by leveraging a proprietary Artificial Intelligence (AI)-driven Integrated Genetic-Epigenetic Engine (“Core Technology”) for cardiovascular disease to become one of the leading medical technology companies for improving prevention, detection, and treatment of cardiovascular disease. For more information, please visit www.cardiodiagnosticsinc.com. Certain statements and information included in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this press release, the words or phrases “will”, "will likely result," "expected to," "will continue," "anticipated," "estimate," "projected," "intend," “goal,” or similar expressions are intended to identify "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are subject to certain risks, known and unknown, and uncertainties, many of which are beyond the control of the Company. Such uncertainties and risks include but are not limited to, our ability to successfully execute our growth strategy, changes in laws or regulations, economic conditions, dependence on management, dilution to stockholders, lack of capital, the effects of rapid growth upon the Company and the ability of management to effectively respond to the growth and demand for products and services of the Company, newly developing technologies, the Company’s ability to compete, regulatory matters, protection of technology, the effects of competition and the ability of the Company to obtain future financing. An extensive list of factors that can affect future results are discussed in the Current Report on Form 10-K for the period ended December 31, 2022 and Form 10-Q for the period ended March 31, 2023, under the heading “Risk Factors” in Part I, Item IA thereof, and other documents filed from time to time with the Securities and Exchange Commission. Such factors could materially adversely affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed within this press release. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Gene Mannheimer - Investor Relations +1 855-226-9991 investors@cardiodiagnosticsinc.com Company Website https://cardiodiagnosticsinc.com/

December 19, 2023 09:25 AM Eastern Standard Time